Kazia Therapeutics KZIA
NASDAQ KZIA
$9.60 -0.15 (-1.54%)
At close: Sep 30, 2026 · 4:00 PM EDT

Kazia Therapeutics (KZIA) Operating Margin (2009)

Updated

Kazia Therapeutics' Operating Margin came in at 756.34% for the year ended Jun 30, 2011, down 180.39 percentage points from 936.73% a year earlier.

Analysis

Kazia Therapeutics (KZIA) Operating Margin (2009) Analysis & Trends

  • Per Business Quant, earlier years put Operating Margin at 936.73% in the year ended Jun 30, 2010 (+756.16 pp) and 180.56% in the year ended Jun 30, 2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 28.21%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 37.86%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -3.52%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 32.97%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 20.57%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 34.95%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -133.21%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 37.40%
10 Kazia Therapeutics 70.77 Mn 70.77 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2009 864.51%
API Access

Kazia Therapeutics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=KZIA&period=max&api_key=YOUR_API_KEY